LEN joins other WHO-recommended PrEP solutions, including daily oral PrEP, injectable cabotegravir and the dapivirine vaginal ring, as part of a rising arsenal of applications to finish the HIV epidemic. Even though use of LEN outside scientific trials remains confined at the moment, WHO urges governments, donors and worldwide overall https://maps.app.goo.gl/wHRWfY833JEXiqNx8